COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,547 Articles (22,881 medRxiv, 8,666 bioRxiv)

Most recent first Previous |  Page 423: Articles 4221-4230  | Next

Clinical Profile, Comorbidities, and Outcome of the Unvaccinated and Hospitalized for COVID-19 in Northern Brazil: Retrospective Cohort
Lucia da Silva Ferreira, A., Sardinha, D. M., Cristina Viana de Moraes, D., Raimunda Rodrigues de Oliveira, M., Carolina Frazao Viana, M., Cristina Oliveira Andrade, N., de Nazare Soares, T., Jose de Paula Souza e Guimaraes, R., Nepomuceno Gondim Costa Lima, L., Valeria Batista Lima, K.
10.1101/2023.06.29.23292037 — Posted: 2023-07-01
Intention to be vaccinated against COVID-19 in Benin and Senegal: a structural equation modelling (SEM)
GAYE, I., Ridde, V., Avahoundjea, E., BA, M. F., DOSSOU, J. p., Diallo, A. I., FAYE, A.
10.1101/2023.06.29.23292061 — Posted: 2023-07-01
Community Antibiotic Prescribing in Patients with COVID-19 Across Three Pandemic Waves: A Population-Based Cohort Study
Ciaccio, L., Donnan, P. T., Parcell, B. J., Marwick, C. A.
10.1101/2023.06.29.23291797 — Posted: 2023-07-01
Pre-pandemic activity on a myalgic encephalomyelitis/chronic fatigue syndrome support forum is highly associated with later activity on a long COVID support forum for a variety of reasons: a mixed methods study.
Meyerson, W. U., Hoyle, R. H.
10.1101/2023.06.30.23292087 — Posted: 2023-07-01
Polymerized type I collagen down-regulates STAT-1 phosphorylation through engagement to LAIR-1 in M1-macrophages avoiding long COVID
Olivares Martinez, E., Hernandez-Ramirez, D. F., Nunez-Alvarez, C. A., Chapa-Ibarguengoitia, M., Mendez-Flores, S., Priego-Ranero, A., Azamar-Llamas, D., Olvera-Prado, H., Rivas-Redonda, K. I., Ochoa-Hein, E., Lopez-Mosqueda, L. G., Rojas-Castaneda, E., Urbina-Teran, S., Septien-Stute, L., Hernandez-Gilsoul, T., Aguilar-Leon, D., Torres-Villalobos, G., Furuzawa-Carballeda, J.
10.1101/2023.07.01.23292108 — Posted: 2023-07-01
Preclinical and Human Phase 1 Studies of Aerosolized Hydroxychloroquine: Implications for Antiviral COVID-19 Therapy
Bentur, O. S., Hutt, R., Brassil, D., Krieger, A. C., Backman, P., Charous, B. L., Boushey, H., Gonda, I., Coller, B. S., MacArthur, R. B.
10.1101/2023.06.22.23291702 — Posted: 2023-07-01
Identification of cross-reacting IgG hotspots to prevent immune evasion of SARS-CoV-2 variants
Harhala, M., Gembara, K., Baniecki, K., Pikies, A., Nahorecki, A., Jedruchniewicz, N., Kazmierczak, Z., Rybicka, I., Klimek, T., Witkiewicz, W., Barczyk, K., Kłak, M., Dabrowska, K.
10.1101/2023.06.27.546805 — Posted: 2023-06-30
The Colloido Osmotic Pressure as a useful biomarker of fatal outcome in pregnant COVID-19 patients
Zavala-Barrios, B., Cerbulo-Vazquez, A., Garcia-Espinosa, M., Caldino-Soto, F., Madera-Sandoval, R. L., Ramirez-Garcia, L. A., Elaceo-Fernandez, I. C., Moreno-Alvarez, O., Guerrero-Avendano, G. M. L., Briones-Garduno, J. C.
10.1101/2023.06.29.23292050 — Posted: 2023-06-30
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Wei, J., Stoesser, N., Matthews, P., Khera, T., Gethings, O., Diamond, I., Studley, R., Taylor, N., peto, t. E., Walker, A. S., Pouwels, K., Eyre, D. W.
10.1101/2023.06.29.23292043 — Posted: 2023-06-30
Synthesis and new evidence from the PROTECT UK National Core Study: Determining occupational risks of SARS-CoV-2 infection and COVID-19 mortality
Rhodes, S., Beale, S., Cherrie, M., Mueller, W., Holland, F., Matz, M., Basinas, I., Wilkinson, J. D., Gittins, M., Farrell, B., Hayward, A., Pearce, N., van Tongeren, M.
10.1101/2023.06.30.23292079 — Posted: 2023-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).